karen barth

Gibbs Law Group

Speaker Bio

Karen Barth Menzies is a nationally-recognized mass tort attorney with more than twenty years of experience in federal and state litigation. Karen is particularly focused on women’s health issues and drugs that cause harm to children.  She currently represents women suffering disfiguring, permanent baldness following breast cancer chemotherapy treatments with Taxotere.  She also advocates for women who developed ovarian cancer after using Johnson & Johnson’s talcum powder products.   

Courts throughout the country have appointed Karen to serve in leadership positions including Lead Counsel, Liaison Counsel and Plaintiff Steering Committee in some of the largest pharmaceutical and device mass tort cases.  Karen has served in leadership positions in the Zoloft Birth Defect Litigation (federal and California state courts), Transvaginal Mesh Litigation (federal and California state courts), Fosamax Femur Fracture Litigation (California state court), Lexapro/Celexa Birth Defect Litigation (Missouri state court); and Paxil Birth Defect Litigation (federal and Pennsylvania state courts) the Paxil Withdrawal Litigation (California federal court) and Paxil Suicide Litigation (federal and state courts around the country).

Karen believes in advocating for drug safety and for the victims in the face of profit-driven corporations. She has testified twice before FDA advisory boards as well as the California State Legislature on the safety concerns regarding the SSRI antidepressants and the manufacturers’ misconduct.  She frequently publishes and presents on issues involving drug safety, mass tort litigation, FDA reform and federal preemption for both legal organizations (plaintiff and defense) and medical groups.  Karen is a member of the Sedona Conference Working Group 1 (Electronic Document Production and Retention) and the Diversity Committee.  Karen is an appointed member of the Plaintiffs’ Policy Task Force for the ABA.  Karen is also actively involved in AAJ, and is currently the Co-Chair of the AAJ Taxotere Litigation Group.